心脏标志物在心血管疾病诊断中的应用进展  

Application progress of cardiac markers in the diagnosis of cardiovascular diseases

作　　者：陈子健 沈逸凡 华召筛 CHEN Zijian;SHEN Yifan;HUA Zhaoshai(RELIA Biotechnologise Jiangsu,Inc,Taizhou 225316,China)

机构地区：[1]瑞莱生物科技江苏有限公司,江苏泰州225316

出　　处：《临床医学研究与实践》2024年第21期190-194,共5页Clinical Research and Practice

摘　　要：随着人口老龄化程度的加深,心血管疾病(CVDs)将会长期处于我国城乡居民死亡原因第一位。不同心脏标志物与各类CVDs均有良好的相关性,可以作为临床诊断和预后的一个重要指标。不同心脏标志物的联合检测灵敏度、准确度和特异度更高,并能应用在不同的CVDs诊断场景,在CVDs的临床应用中有重要意义。With the deepening of the aging of the population,the cardiovascular diseases(CVDs)will be the first cause of death for urban and rural residents in China for a long time.Different cardiac markers have a good correlation with various CVDs,it can be used as an important indicator of clinical diagnosis and prognosis.The combined detection of different cardiac markers has higher sensitivity,accuracy and specificity,and can be applied in different CVDs diagnosis scenarios,which is of great significance in the clinical application of CVDs.

关 键 词：心脏标志物 生物标志物 联合检测 心血管疾病 心力衰竭 心肌梗死 

分 类 号：R542.2[医药卫生—心血管疾病]